Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma

SIMPLE SUMMARY: Neurofibromatosis type 2 (NF2) is a rare genetic hereditary disease characterized by multiple central nervous system tumors, most frequently bilateral vestibular schwannomas (VSs). No chemotherapeutic agents are available for clinical use, and surgery and radiotherapy are the only th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Curr Oncol
Main Authors: Fujii, Masazumi, Kobayakawa, Masao, Saito, Kiyoshi, Inano, Akihiro, Morita, Akio, Hasegawa, Mitsuhiro, Mukasa, Akitake, Mitsuhara, Takafumi, Goto, Takeo, Yamaguchi, Shigeru, Tamiya, Takashi, Nakatomi, Hirofumi, Oya, Soichi, Takahashi, Fumiaki, Sato, Taku, Bakhit, Mudathir
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2021
Fag:
Study Protocol
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7985777/
https://ncbi.nlm.nih.gov/pubmed/33572546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28010071
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker